Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
716 (USA) · Dr. Ito
consented 2012-10-09
AEs
4
Serious
0
Dropout signal
–
Adverse events
moderate
assessed
Moderate DELUSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-11-24 (study day 47.0); relationship: NONE
moderate
assessed
Moderate HALLUCINATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-11-24 (study day 47.0); relationship: NONE
severe
assessed
Severe PROSTATE CANCER — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-07 (study day 122.0); relationship: NONE
mild
assessed
Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-05 (study day 89.0); relationship: POSSIBLE
Data queries
No data queries.